藥物上市前須經過人體試驗,參與藥物臨床試驗的受試者將承擔不同程度的風險,我國GCP明確規定要充分保障受試者的權益,倫理委員會和知情同意書是保障受試者權益的主要措施,但在實際中仍存在不少問題。為此,如何切實保障受試者的權益,是臨床試驗所要解決的一個重要問題。
Citation: SHEN Qi,LIANG Derong,WU Songze. Few Wands of Subjects Protection,Rights and Benefits in Clinical Trials. West China Medical Journal, 2009, 24(2): 342-343. doi: Copy
Copyright ? the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved

